Hiroki Kuniyasu
About
In The Last Decade
Hiroki Kuniyasu
269 papers receiving 10.2k citations
Peers
Comparison fields: 5 of 129
- Molecular Biology 5.4k
- Oncology 3.1k
- Cancer Research 2.2k
- Pulmonary and Respiratory Medicine 1.6k
- Surgery 1.4k
Countries citing papers authored by Hiroki Kuniyasu
This map shows the geographic impact of Hiroki Kuniyasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kuniyasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kuniyasu more than expected).
Fields of papers citing papers by Hiroki Kuniyasu
This network shows the impact of papers produced by Hiroki Kuniyasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kuniyasu. The network helps show where Hiroki Kuniyasu may publish in the future.
Co-authorship network of co-authors of Hiroki Kuniyasu
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Kuniyasu. A scholar is included among the top collaborators of Hiroki Kuniyasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Kuniyasu. Hiroki Kuniyasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 17 | |
| 6 | 15 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 4 | |
| 10 | 25 | |
| 11 | 11 | |
| 12 | 13 | |
| 13 | 20 | |
| 14 | 8 | |
| 15 | Interleukin-15 and transforming growth factor alpha are associated with depletion of tumor-associated macrophages in colon cancer. | 19 |
| 16 | Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. | 45 |
| 17 | 6 | |
| 18 | Abnormal expression of growth factors and their receptors in stomach cancer | 5 |
| 19 | Expression of cripto in human gastric carcinomas : An association with tumor stage and prognosis | 18 |
| 20 | [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers]. | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.